BerganKDV Wealth Management’s iShares Russell 2000 Growth ETF IWO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$12.1K Hold
50
﹤0.01% 541
2023
Q1
$11.3K Sell
50
-22
-31% -$5.03K ﹤0.01% 583
2022
Q4
$15.4K Buy
72
+22
+44% +$4.82K ﹤0.01% 521
2022
Q3
$10K Hold
50
﹤0.01% 571
2022
Q2
$10K Hold
50
﹤0.01% 596
2022
Q1
$13K Sell
50
-10
-17% -$2.56K ﹤0.01% 576
2021
Q4
$18K Hold
60
﹤0.01% 560
2021
Q3
$18K Buy
60
+50
+500% +$15K ﹤0.01% 545
2021
Q2
$3K Buy
+10
New +$3.01K ﹤0.01% 765
2020
Q1
Sell
-46
Closed -$10K 968
2019
Q4
$10K Hold
46
﹤0.01% 528
2019
Q3
$9K Hold
46
﹤0.01% 512
2019
Q2
$9K Hold
46
﹤0.01% 529
2019
Q1
$9K Hold
46
﹤0.01% 541
2018
Q4
$8K Hold
46
﹤0.01% 508
2018
Q3
$10K Hold
46
﹤0.01% 490
2018
Q2
$9K Buy
+46
New +$9.2K ﹤0.01% 514

Other funds holding IWO

BerganKDV Wealth Management's IWO Position: Q2 2023 in Review

BerganKDV Wealth Management held its iShares Russell 2000 Growth ETF (IWO) position steady in Q2 2023 at 50 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #541.

BerganKDV Wealth Management first reported a position in IWO in Q2 2018 and has held it in 16 quarters since. The position peaked at $18K in Q4 2021. 830 funds tracked by Wall St. Rank hold IWO as of Q2 2023.

  • BerganKDV Wealth Management held 50 shares of iShares Russell 2000 Growth ETF worth $12.1K as of Q2 2023.
  • BerganKDV Wealth Management left its iShares Russell 2000 Growth ETF share count unchanged in Q2 2023.
  • iShares Russell 2000 Growth ETF made up ﹤0.01% of BerganKDV Wealth Management's portfolio in Q2 2023, its #541 holding.
  • BerganKDV Wealth Management first reported a position in iShares Russell 2000 Growth ETF in Q2 2018 and has held it in 16 quarters since.
  • BerganKDV Wealth Management's iShares Russell 2000 Growth ETF position peaked at $18K in Q4 2021.
  • 830 funds tracked by Wall St. Rank held iShares Russell 2000 Growth ETF as of Q2 2023.

Based on BerganKDV Wealth Management's 13F filing for Q2 2023, filed 24 Jul 2023.